Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
Conditions: NSCLC; Non-small Cell Lung Cancer Intervention: Drug: Osimertinib Sponsor: Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Neurology | Non-Small Cell Lung Cancer